Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 64   

Articles published

JNJ 100.50 -3.40 (-3.27%)
price chart
Johnson & Johnson to open life science centres
Johnson & Johnson is to open four life science “innovation centres” as it decentralises decisions on investment and partnerships to boost productivity.
Johnson & Johnson sets up SF center  San Francisco Chronicle
Johnson & Johnson to open 'innovation centers' in Bay Area, globally  Bizjournals.com (blog)
J.&J. Names Outsider to Run Its Troubled Consumer Unit
Johnson & Johnson named an outsider on Thursday to fill a top leadership role overseeing its troubled consumer health unit, a break from the company's longstanding tradition of promoting executives from within.
Johnson & Johnson Hires Former Bayer Exec To Combat Mounting Porblems  ValueWalk
Bayer AG exec picks up reins at J&J's troubled consumer product biz  FierceBiotech
Johnson & Johnson Launches Be Vital Challenge to Reward College Student ...
NEW BRUNSWICK, N.J., Sept. 18, 2012 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) is launching a challenge to reward college student organizations for their effort in taking care of the world we share.
Lawyers in Risperdal case argue Johnson & Johnson's CEO should be called to ...
Johnson & Johnson's top executive should be forced to testify about claims that the company illegally marketed the antipsychotic drug Risperdal, which allegedly caused boys to grow breasts, lawyers for a teenager suing the drugmaker said in a court filing.
Johnson & Johnson Report: 54% of Hospitals Say Green Attributes Important in ...
More than one-third (35 percent) of hospitals surveyed switched suppliers to gain access to sustainable health-care products, according to a new report by Johnson & Johnson that finds hospitals are placing greater emphasis on “green” products used in ...
Future Impact of Environmental Scorecards, Hospital Global Purchasing ...  CSRwire.com (press release)
Lawyer Fights $10 Million Fee For "Cosmetic" Johnson And Johnson Settlement
Ted Frank's Center for Class Action Fairness has challenged a settlement that would pay the lawyers who negotiated it $10 million and give their ostensible clients - Johnson & Johnson shareholders - nothing. Correct that. Since this is a so-called ...
Procter & Gamble Takes Over #11 Spot From Johnson & Johnson
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Procter & Gamble Co.
Johnson & Johnson - Life After The Patent Cliff?
Johnson & Johnson (NYSE:JNJ) saw the patents for its antibiotic, Levaquin (Floxin), and its ADHD/ADD drug, Concerta, expire in 2011.
J&J Settles Risperdal Lawsuit on Opening Day of Trial
Johnson & Johnson settled a lawsuit on the first day of a trial over claims its antipsychotic drug Risperdal caused a male plaintiff to grow breast tissue, one of his lawyers told a state judge in Philadelphia.
J&J Sees Male Breasts And Quickly Settles Risperdal Suit  Forbes
J&J Settles Pa. Risperdal Lawsuit On Opening Day of Trial  Law360 (subscription)
Transvaginal Mesh Lawsuit Alleges Johnson & Johnson's Gynecare Gynemesh ...
BOSTON--(BUSINESS WIRE)--Gilman Law LLP has filed a transvaginal mesh lawsuit on behalf of a woman from Missouri who suffered severe complications, including the need for two additional surgeries, following implantation of Johnson & Johnson's ...